2006
DOI: 10.1097/01.tp.0000225764.21343.e3
|View full text |Cite
|
Sign up to set email alerts
|

Early Pancreas Transplant Outcomes with Histidine-Tryptophan-Ketoglutarate Preservation: A Multicenter Study

Abstract: Little is known about the use of histidine-tryptophan-ketoglutarate (HTK) preservation solution for pancreas preservation. We compared early pancreas graft outcomes at four pancreas transplant programs within the state of Michigan in 2002 and 2003 (University of Wisconsin [UW] era) with those in 2004 (HTK era). The primary endpoint was early graft loss. The UW group (n=41) and the HTK group (n=36) had similar outcomes with respect to: technical graft loss (9.8% vs. 8.3%, P=NS), 90-day graft function (90.2% vs.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
40
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(43 citation statements)
references
References 14 publications
3
40
0
Order By: Relevance
“…Furthermore, A closer examination of the allograft survival curves in Figure 2 suggested a dominant early effect of preservation solution; this was consistent with a recent single-center report (2). To differentiate between early and late effects in the national population, we developed a multivariate Reduced Pancreas Graft Survival with HTK these results are the short CIT (<12 h) in this (4) and prior case series (2,(5)(6)(7)(8)(9) (13)(14)(15)(16)(17). These gross findings also correlated with histological evidence of increased interstitial edema and cellular swelling (15)(16)(17).…”
Section: Methodssupporting
confidence: 77%
“…Furthermore, A closer examination of the allograft survival curves in Figure 2 suggested a dominant early effect of preservation solution; this was consistent with a recent single-center report (2). To differentiate between early and late effects in the national population, we developed a multivariate Reduced Pancreas Graft Survival with HTK these results are the short CIT (<12 h) in this (4) and prior case series (2,(5)(6)(7)(8)(9) (13)(14)(15)(16)(17). These gross findings also correlated with histological evidence of increased interstitial edema and cellular swelling (15)(16)(17).…”
Section: Methodssupporting
confidence: 77%
“…The reasons for replacement of UWS by HTK can be partially related to economic considerations [25]. In agreement with numerous studies evaluating the effect of HTK on pancreas [2,4,6,7,26], kidney [27], and liver transplantation [3], the only islet studies that have been performed so far did not find any significant difference between HTK and UWS with regard to isolation and post-transplant outcome [12,13,28]. In contrast, several multicenter studies provided opposite results for pancreas [8], kidney [10,24], and liver transplantation [11].…”
Section: Discussionsupporting
confidence: 65%
“…Furthermore, the lower viscosity of HTK seems to facilitate enhanced clearance of organs from blood compared with UWS [4]. In pancreas transplantation, the majority of the current reports did not reveal any significant differences between UWS and HTK with respect to graft survival [2,[5][6][7]. Nevertheless, two studies analyzing more than 4000 pancreas transplants have raised concerns about the efficiency of HTK, particularly if utilized for prolonged cold ischemia time (CIT) [8,9].…”
Section: Introductionmentioning
confidence: 93%
“…We reviewed our experience with HTKflushed pancreata to determine whether there was a basis for suspecting a causal relationship. (6)(7)(8).…”
Section: The Food and Drug Administration (Fda) Approved Histidine-trmentioning
confidence: 99%